HSV-1 and Alzheimer’s disease: more than a hypothesis
暂无分享,去创建一个
Enrico Garaci | A. Palamara | E. Garaci | C. Grassi | Roberto Piacentini | Giovanna De Chiara | Domenica D. Li Puma | Cristian Ripoli | Maria E. Marcocci | Anna T. Palamara | Claudio Grassi | R. Piacentini | C. Ripoli | M. Marcocci | G. De Chiara | D. D. Li Puma | M. E. Marcocci
[1] J W DUGGAN,et al. Herpes simplex virus. , 1961, Transactions of the Canadian Ophthalmological Society.
[2] D. Pavan-Langston,et al. Acylovir in oral and ganglionic herpes simplex virus infections. , 1979, The Journal of infectious diseases.
[3] D. Pavan-Langston,et al. Acyclovir in Oral and Ganglionic Herpes Simplex Virus Infections , 1979 .
[4] M. Ball. “Limbic Predilection in Alzheimer Dementia: Is Reactivated Herpesvirus Involved?” , 1982, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[5] H Gordan,et al. Herpes simplex. , 1982, International journal of dermatology.
[6] P. Doherty,et al. Central nervous system infection and immune response in mice inoculated into the lip with herpes simplex virus type 1 , 1982, Journal of Neuroimmunology.
[7] A R Damasio,et al. The limbic system and the localisation of herpes simplex encephalitis. , 1985, Journal of neurology, neurosurgery, and psychiatry.
[8] D. Selkoe,et al. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[9] D. Selkoe,et al. Microtubule-associated protein tau (? ) is a major antigenic component of paired helical filaments in Alzheimer disease , 1987 .
[10] E. Lavi,et al. Latent herpes simplex virus type 1 transcripts in peripheral and central nervous system tissues of mice map to similar regions of the viral genome , 1988, Journal of virology.
[11] N. A. Kefalides,et al. Lithium chloride restores host protein synthesis in herpes simplex virus-infected endothelial cells. , 1989, Biochemical and biophysical research communications.
[12] G. Wilcock,et al. Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type , 1992, The Journal of pathology.
[13] Mark P. Mattson,et al. β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease , 1993, Trends in Neurosciences.
[14] N. A. Kefalides,et al. Lithium chloride suppresses the synthesis of messenger RNA for infected cell protein-4 and viral deoxyribonucleic acid polymerase in herpes simplex virus-1 infected endothelial cells. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[15] J. Amsterdam,et al. Suppression of Herpes Simplex Virus Infections with Oral Lithium Carbonate—A Possible Antiviral Activity , 1996, Pharmacotherapy.
[16] R. Doms,et al. Alzheimer's Aβ(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells , 1997, Nature Medicine.
[17] G. Wilcock,et al. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease , 1997, The Lancet.
[18] R. Itzhaki,et al. Herpes simplex virus type I in brain and the type 4 allele of the apolipoprotein E gene are a combined risk factor for Alzheimer's disease. , 1998, Biochemical Society transactions.
[19] J. Poirier,et al. HSV-1 in brain and risk of Alzheimer's disease , 1998, The Lancet.
[20] W. März,et al. Apolipoprotein E Isoforms Increase Intracellular Ca2+ Differentially Through a ω‐Agatoxin IVa‐Sensitive Ca2+‐Channel , 1998, Brain pathology.
[21] E. Mandelkow,et al. Tau in Alzheimer's disease. , 1998, Trends in cell biology.
[22] M. Wozniak,et al. ApoE–viral interactions , 1998, Nature Medicine.
[23] M. Tabaton,et al. Alternative, Non-secretase Processing of Alzheimer’s β-Amyloid Precursor Protein during Apoptosis by Caspase-6 and -8* , 1999, The Journal of Biological Chemistry.
[24] David Smith,et al. Involvement of Caspases in Proteolytic Cleavage of Alzheimer’s Amyloid-β Precursor Protein and Amyloidogenic Aβ Peptide Formation , 1999, Cell.
[25] J. Treanor,et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.
[26] D. Small,et al. Regulation of APP cleavage by α‐, β‐ and γ‐secretases , 2000 .
[27] C. Cotman,et al. Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer's A beta peptide. , 2000, Biochemistry.
[28] A. Fagan,et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[29] C. Cotman,et al. Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to Alzheimer’ β amyloid peptide , 2000 .
[30] J. Peter,et al. Review of 3200 serially received CSF samples submitted for type-specific HSV detection by PCR in the reference laboratory setting. , 2001, Molecular and cellular probes.
[31] G. Prince,et al. Herpes simplex type 1 infects and establishes latency in the brain and trigeminal ganglia during primary infection of the lip in cotton rats and mice , 2002, Archives of Virology.
[32] M. Bullido,et al. Involvement of Apolipoprotein E in the Hematogenous Route of Herpes Simplex Virus Type 1 to the Central Nervous System , 2002, Journal of Virology.
[33] C. Blake. Amyloid Precursor Protein , 2002 .
[34] L. Tsai,et al. APP processing is regulated by cytoplasmic phosphorylation , 2003, The Journal of cell biology.
[35] K. Hsu,et al. Herpes simplex virus type 1 inoculation enhances hippocampal excitability and seizure susceptibility in mice , 2003, The European journal of neuroscience.
[36] M. Bullido,et al. ApoE4 is more efficient than E3 in brain access by herpes simplex virus type 1 , 2003, Neuroreport.
[37] D. Bredesen,et al. Caspase cleavage of the amyloid precursor protein modulates amyloid β‐protein toxicity , 2003, Journal of neurochemistry.
[38] M. Mattson,et al. Calcium orchestrates apoptosis , 2003, Nature Cell Biology.
[39] M. Wozniak,et al. Do infectious agents play a role in dementia? , 2003, Trends in microbiology.
[40] F. LaFerla,et al. Microglia as a Potential Bridge between the Amyloid β‐Peptide and Tau , 2004 .
[41] A. Verier,et al. Cognitive and psychiatric impairment in herpes simplex virus encephalitis suggest involvement of the amygdalo-frontal pathways , 1996, Journal of Neurology.
[42] J. Friedman,et al. A randomized clinical trial of valacyclovir in multiple sclerosis , 2005, Multiple sclerosis.
[43] R. Itzhaki,et al. Herpes simplex virus interferes with amyloid precursor protein processing , 2005, BMC Microbiology.
[44] J. Alfaro,et al. Herpes Simplex Virus Type 1 Infection via the Bloodstream with Apolipoprotein E Dependence in the Gonads Is Influenced by Gender , 2005, Journal of Virology.
[45] M. Ball,et al. Statins lower the risk of developing Alzheimer's disease by limiting lipid raft endocytosis and decreasing the neuronal spread of Herpes simplex virus type 1. , 2005, Medical hypotheses.
[46] Hui Zheng,et al. Molecular Neurodegeneration BioMed Central Review The amyloid precursor protein: beyond amyloid , 2006 .
[47] J. Brion,et al. Calcium-mediated Transient Phosphorylation of Tau and Amyloid Precursor Protein Followed by Intraneuronal Amyloid-β Accumulation* , 2006, Journal of Biological Chemistry.
[48] Gopal Thinakaran,et al. Amyloidogenic processing of β-amyloid precursor protein in intracellular compartments , 2006, Neurology.
[49] J. Alfaro,et al. Hematogenous Vertical Transmission of Herpes Simplex Virus Type 1 in Mice , 2006, Journal of Virology.
[50] Y. Suh,et al. Phosphorylation of Amyloid Precursor Protein (APP) at Thr668 Regulates the Nuclear Translocation of the APP Intracellular Domain and Induces Neurodegeneration , 2006, Molecular and Cellular Biology.
[51] J. Burgos,et al. Effect of Apolipoprotein E on the Cerebral Load of Latent Herpes Simplex Virus Type 1 DNA , 2006, Journal of Virology.
[52] C. Almeida,et al. Internalized Antibodies to the Aβ Domain of APP Reduce Neuronal Aβ and Protect against Synaptic Alterations*♦ , 2007, Journal of Biological Chemistry.
[53] B. Ibach,et al. Detection of Herpesvirus DNA in Cerebrospinal Fluid and Correlation with Clinical Symptoms , 2008, Infection.
[54] M. Wozniak,et al. Herpes simplex virus infection causes cellular β-amyloid accumulation and secretase upregulation , 2007, Neuroscience Letters.
[55] P. Barberger‐Gateau,et al. Seropositivity to Herpes Simplex Virus Antibodies and Risk of Alzheimer's Disease: A Population-Based Cohort Study , 2008, PloS one.
[56] C. Carter. Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: Relevance to pathological-signalling cascades , 2008, Neurochemistry International.
[57] M. Wozniak,et al. Susceptibility to herpes simplex labialis conferred by the gene encoding apolipoprotein E. , 2008, The Journal of infectious diseases.
[58] C. Otth,et al. Neuronal cytoskeletal dynamic modification and neurodegeneration induced by infection with herpes simplex virus type 1. , 2008, Journal of Alzheimer's disease : JAD.
[59] A. Palmeri,et al. Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus , 2008, The Journal of Neuroscience.
[60] Y. Kawaguchi,et al. Primary target cells of herpes simplex virus type 1 in the hippocampus. , 2008, Microbes and infection.
[61] H. Fukuyama,et al. Peripheral Aβ subspecies as risk biomarkers of Alzheimer's disease , 2008, Proceedings of the National Academy of Sciences.
[62] C. Grassi,et al. Role of methionine 35 in the intracellular Ca2+ homeostasis dysregulation and Ca2+‐dependent apoptosis induced by amyloid β‐peptide in human neuroblastoma IMR32 cells , 2008, Journal of neurochemistry.
[63] F. Michetti,et al. Dysregulation of intracellular calcium homeostasis is responsible for neuronal death in an experimental model of selective hippocampal degeneration induced by trimethyltin , 2008, Journal of neurochemistry.
[64] D. Bredesen,et al. Signal transduction in Alzheimer disease: p21‐activated kinase signaling requires C‐terminal cleavage of APP at Asp664 , 2008, Journal of neurochemistry.
[65] L. Buée,et al. Association of plasma amyloid β with risk of dementia , 2009, Neurology.
[66] L. Buée,et al. Association of plasma amyloid β with risk of dementia , 2009, Neurology.
[67] Yuhai Zhao,et al. HSV-1 infection of human brain cells induces miRNA-146a and Alzheimer-type inflammatory signaling , 2009, Neuroreport.
[68] M. Wozniak,et al. Alzheimer's disease-specific tau phosphorylation is induced by herpes simplex virus type 1. , 2009, Journal of Alzheimer's disease : JAD.
[69] K. Green. Calcium in the initiation, progression and as an effector of Alzheimer’s disease pathology , 2009, Journal of cellular and molecular medicine.
[70] D. Holtzman,et al. The Role of Apolipoprotein E in Alzheimer's Disease , 2009, Neuron.
[71] MA Wozniak,et al. Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques , 2009, The Journal of pathology.
[72] E. Porcellini,et al. Alzheimer's disease gene signature says: beware of brain viral infections , 2010, Immunity & Ageing.
[73] R. Rubey. Could lysine supplementation prevent Alzheimer’s dementia? A novel hypothesis , 2010, Neuropsychiatric disease and treatment.
[74] A. Palamara,et al. APP Processing Induced by Herpes Simplex Virus Type 1 (HSV-1) Yields Several APP Fragments in Human and Rat Neuronal Cells , 2010, PloS one.
[75] Huaxi Xu,et al. APP processing in Alzheimer's disease , 2011, Molecular Brain.
[76] M. Weiner,et al. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease , 2010, Nature Reviews Neurology.
[77] E. Porcellini,et al. Gene signature in Alzheimer's disease and environmental factors: the virus chronicle. , 2011, Journal of Alzheimer's disease : JAD.
[78] P. Webster,et al. Herpes Simplex Virus Dances with Amyloid Precursor Protein while Exiting the Cell , 2011, PloS one.
[79] A. Palamara,et al. HSV-1 promotes Ca2+-mediated APP phosphorylation and Aβ accumulation in rat cortical neurons , 2011, Neurobiology of Aging.
[80] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[81] A. Palmeri,et al. Endogenous amyloid‐β is necessary for hippocampal synaptic plasticity and memory , 2011, Annals of neurology.
[82] Donald H. Lee,et al. Herpes simplex encephalitis presenting with exclusively frontal lobe involvement , 2011, Journal of NeuroVirology.
[83] L. Buée,et al. Association between IgM Anti-Herpes Simplex Virus and Plasma Amyloid-Beta Levels , 2011, PloS one.
[84] C. M. Preston,et al. Antivirals Reduce the Formation of Key Alzheimer's Disease Molecules in Cell Cultures Acutely Infected with Herpes Simplex Virus Type 1 , 2011, PloS one.
[85] G. Bitan,et al. Surprising toxicity and assembly behaviour of amyloid β-protein oxidized to sulfone. , 2011, The Biochemical journal.
[86] E. Posse de Chaves,et al. Aβ Internalization by Neurons and Glia , 2011, International journal of Alzheimer's disease.
[87] K. Vío,et al. Tau cleavage at D421 by caspase-3 is induced in neurons and astrocytes infected with herpes simplex virus type 1. , 2011, Journal of Alzheimer's disease : JAD.
[88] J. Richardson,et al. Stabilizing ER Ca2+ Channel Function as an Early Preventative Strategy for Alzheimer’s Disease , 2012, PloS one.
[89] E. Bearer. HSV, axonal transport and Alzheimer's disease: in vitro and in vivo evidence for causal relationships. , 2012, Future virology.
[90] R. Schekman,et al. Amyloid precursor protein (APP) traffics from the cell surface via endosomes for amyloid β (Aβ) production in the trans-Golgi network , 2012, Proceedings of the National Academy of Sciences.
[91] C. Jack,et al. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study , 2012, The Lancet Neurology.
[92] Daniel A Bórquez,et al. The Amyloid Precursor Protein Intracellular Domain-Fe65 Multiprotein Complexes: A Challenge to the Amyloid Hypothesis for Alzheimer's Disease? , 2012, International journal of Alzheimer's disease.
[93] O. Forlenza,et al. Does Lithium Prevent Alzheimer’s Disease? , 2012, Drugs & Aging.
[94] J. Richardson,et al. Stabilizing ER Ca 2 + Channel Function as an Early Preventative Strategy for Alzheimer ’ s Disease , 2012 .
[95] L. Mucke,et al. Neurotoxicity of amyloid β-protein: synaptic and network dysfunction. , 2012, Cold Spring Harbor perspectives in medicine.
[96] Guojun Bu,et al. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.
[97] D. Holtzman,et al. Apolipoprotein E, Especially Apolipoprotein E4, Increases the Oligomerization of Amyloid β Peptide , 2012, The Journal of Neuroscience.
[98] M. Wozniak,et al. Could antivirals be used to treat Alzheimer's disease? , 2012, Future microbiology.
[99] G. Bitan,et al. Effects of different amyloid β-protein analogues on synaptic function , 2013, Neurobiology of Aging.
[100] Shunichiro Shinagawa,et al. Increase in the IgG avidity index due to herpes simplex virus type 1 reactivation and its relationship with cognitive function in amnestic mild cognitive impairment and Alzheimer's disease. , 2013, Biochemical and biophysical research communications.
[101] N. Nalivaeva,et al. From synaptic spines to nuclear signaling: nuclear and synaptic actions of the amyloid precursor protein , 2013, Journal of neurochemistry.
[102] J. Padmanabhan,et al. Altered Processing of Amyloid Precursor Protein in Cells Undergoing Apoptosis , 2013, PloS one.
[103] H. Buck,et al. Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer's disease. , 2013, Current Alzheimer research.
[104] Hilmar Bading,et al. Nuclear calcium signalling in the regulation of brain function , 2013, Nature Reviews Neuroscience.
[105] A. Shah,et al. ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions , 2013, Proceedings of the National Academy of Sciences.
[106] E. Calabrese,et al. Titers of herpes simplex virus type 1 antibodies positively correlate with grey matter volumes in Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.
[107] R. Whitley,et al. Herpes simplex virus. , 2014, Handbook of clinical neurology.
[108] H. Soininen,et al. Future directions in Alzheimer's disease from risk factors to prevention. , 2014, Biochemical pharmacology.
[109] D. Butterfield,et al. Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets. , 2014, Biochemical pharmacology.
[110] K. Vío,et al. Inflammatory and neurodegeneration markers during asymptomatic HSV-1 reactivation. , 2014, Journal of Alzheimer's disease : JAD.
[111] M. Pardo,et al. Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments. , 2014, Pharmacology & therapeutics.